Announcement on Obtaining Drug Registration Certificate for Some Drugs by Subsidiary
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Filed with SSE · · 7 pages · Chinese
China Resources Double-Crane Pharmaceutical Co., Ltd. announced that its subsidiaries have obtained drug registration certificates for several products. The registered drugs include Linagliptin and Metformin Hydrochloride Tablets, Progesterone Injection, and Vortioxetine Hydrobromide Tablets. The filing also includes a risk warning regarding the uncertainties in the pharmaceutical market.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
On 6ix: 6ix.com/news/announcement-on-obtaining-drug-registration-certificate-for-some-drugs-by-subsidiary
Announcement on Obtaining Drug Registration Certificate for Some Drugs by Subsidiary
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
China Resources Double-Crane Pharmaceutical Co., Ltd. on 6ix
Follow China Resources Double-Crane Pharmaceutical into a list and get an email when it puts out news.
Follow China Resources Double-Crane Pharmaceutical